Drugs with verified catalysts

Name: Bio Catalyst Calendar — source-anchored biotech/pharma catalyst dates
Creator: Bio Catalyst Calendar
License: https://www.usa.gov/government-works

592 drugs/products referenced in verified catalyst events. Verified as of 2026-06-22.

Drug	Catalysts
TPSAC	4
Efgartigimod PH20 SC	3
Ruxolitinib Cream, Vehicle Cream	3
Nemolizumab	3
Tirzepatide	3
Litifilimab	3
KarXT	3
DIVALPROEX SODIUM	3
Amlitelimab	2
ferumoxytol, Iron sucrose	2
DT120	2
MAR001	2
TAK-360	2
INCB099280	2
Remibrutinib, Teriflunomide	2
Bimekizumab	2
18F-MFBG	2
YL202 should be intravenously infused	2
EYP-1901, Aflibercept (2.0 mg)	2
Briquilimab	2
Fitusiran	2
Dazodalibep	2
LP352	2
KHK4951, Aflibercept Injection	2
DISC-0974	2
Lu AG13909	2
TAK-279	2
Sonrotoclax, Zanubrutinib	2
barzolvolimab, Matching placebo	2
Leniolisib	2
Itepekimab (SAR440340), Mometasone furoate nasal spray (MFNS)	2
Deucravacitinib	2
Povorcitinib	2
Cenerimod	2
FBX-101	2
IMU-838 tablets	2
SKYRIZI	2
FDORA	2
COVID	2
Iopofosine I 131 single dose, Iopofosine I 131 multiple dose, Iopofosine I 131 fractionated dose	1
Odevixibat	1
itacitinib	1
Rocatinlimab	1
GSK4418959, PD-1 inhibitor	1
Garadacimab	1
Nipocalimab	1
Elafibranor	1
JNJ-89495120	1
HM15211	1
WVE-N531	1
Plixorafenib	1
Olaparib, Pembrolizumab	1
ALK-001	1
ZYN002 - Cannabidiol Transdermal Gel	1
doxecitine and doxribtimine	1
NanO2TM	1
Orelabrutinib (ICP-022)	1
TQJ230	1
ONC-392, Pembrolizumab, Docetaxel	1
UCART22, CLLS52	1
P1101 (Ropeginterferon alfa-2b)	1
Mosunetuzumab, Lenalidomide, Rituximab, Tociluzumab	1
EG-70 (phase 1), EG-70 (phase 2) Master Protocol, Surfactant Bladder Pre-Rinse and EG-70 (Substudy)	1
rAAV2tYF-GRK1-hRPGRco, Control	1
Lomecel-B medicinal signaling cells	1
68Ga-FAP-2286, 177Lu-FAP-2286	1
NP-G2-044 Monotherapy, Anti-PD-1 Therapy, NP-G2-044 Combination therapy	1
Staccato alprazolam	1
MDNA11, Pembrolizumab (KEYTRUDA®)	1
PTC923	1
TU2218, Anti-PD-1 antibody	1
Amezosvatein Antigen High Dose Arm A, Amezosvatein Antigen Low Dose Arm B, Shingrix, Amezosvatein Adjuvant Dose Arm D	1
HLX10, carboplatin/cisplatin-etoposide, Thoracic radiotherapy, Prophylactic Cranial Irradiation (PCI)	1
contezolid acefosamil (IV)/contezolid (PO), Linezolid (IV and PO)	1
Gedatolisib, Palbociclib, Fulvestrant, Alpelisib	1
mRNA-1468, Shingrix	1
Obexelimab, Obexelimab	1
SKB264, Pembrolizumab, Carboplatin, Osimertinib	1
Redasemtide	1
Palazestrant, Fulvestrant, Anastrozole, Letrozole	1
HY209GEL Active	1
TRK-950, Ramucirumab, Paclitaxel	1
GSK4524101, Niraparib	1
Saline Injection 0.9%, Indigotindisulfonate sodium 0.8%	1
LM-24C5	1
Dostarlimab, Belrestotug, Pembrolizumab	1
NSI-8226, NSI-8226, NSI-8226	1
Biological: Solrikitug low dose, Biological: Solrikitug high dose	1
BW-00112	1
Claseprubart	1
Aroxybutynin and Atomoxetine	1
Sacituzumab tirumotecan, Rescue medication, Supportive care measures	1
BW-20805, BW-20805, BW-20805	1
YA-101	1
IgPro	1
Nirsevimab	1
Vimseltinib	1
Telisotuzumab vedotin	1
Bimatoprost SR	1
RAPA-501 Autologous T stem cells	1
HBI-8000 in combination with nivolumab	1
HM15136	1
CAM2029, Octreotide LAR, Lanreotide ATG	1
D07001-softgel capsules + Xeloda (or TS-1), mFOLFOX	1
Fasudil (WP-0512), Fasudil (WP-0512)	1
Modi-1 Moditope, Pembrolizumab, MicronJet600™ microneedle device (NanoPass)	1
povetacicept	1
Upadacitinib, Adalimumab, Upadacitinib Matching Placebo, Adalimumab Matching Placebo	1
CJRB-101, Pembrolizumab injection	1
Envudeucitinib	1
Antibody-Drug Conjugate	1
Durvalumab, Bevacizumab, Transarterial Radioembolization (TARE)	1
Givinostat, Hydroxyurea	1
Lenacapavir Tablet, Lenacapavir Injection, Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF)	1
Nizaracianine Triflutate	1
MANP	1
Pitolisant tablet	1
Auxora	1
ProAgio Dose Levels (DL) 1,2,3,4, ProAgio Dose Expansion	1
Hypericin	1
Sotagliflozin	1
Tenapanor	1
TLC590, TLC590, TLC590, TLC590	1
GTX-102	1
BRII-179, BRII-835 (VIR-2218), PEG-IFNα	1
Mirvetuximab Soravtansine	1
Halneuron, Halneuron (Open Label Extension)	1
ONO-2020	1
Leflutrozole, Dose 1, Leflutrozole, Dose 2, Leflutrozole, Dose 3	1
SION-719	1
Boric acid	1
Anktiva	1
EVO756, EVO756, EVO756	1
VRDN-003, Autoinjector	1
Combination Product: FDC of spironolactone and ER torsemide, Combination Product: Stabilized doses of loop diuretic and finerenone	1
4P004	1
VENT-03	1
VRB-101	1
QLS-111-FDC, Latanoprost (0.005%)	1
Max Fresh Toothpaste, Colgate Cavity Protection Toothpaste	1
Naloxone Hydrochloride, Fentanyl, Sterile Saline, CS-1103	1
BMS-986435	1
INCA034176	1
Odronextamab	1
Trastuzumab deruxtecan, Taxane, Pertuzumab, Trastuzumab	1
Osimertinib, Cisplatin or Carboplatin; Pemetrexed or Paclitaxel, Radiation	1
Nivolumab, Ipilimumab, Sorafenib, lenvatinib	1
Mavacamten	1
SAR441344 IV, SAR441344 SC	1
GX-03, Vehicle	1
PF-06821497, Docetaxel, Enzalutamide	1
Ruxolitinib, Vehicle Cream	1
Tezepelumab, Tezepelumab	1
mibavademab	1
30 minute photoactivation of riboflavin 0.1%, 10 minute photoactivation of riboflavin 0.1%	1
Ravulizumab	1
SP-624	1
Namodenoson 25mg	1
IMM01-STEM, IMM01-STEM alternating with placebo (saline)	1
Pembrolizumab, Favezelimab/Pembrolizumab, Belzutifan, Lenvatinib	1
Pembrolizumab, MK-4830, Belzutifan, Lenvatinib	1
GSK5784283	1
Mezigdomide, Carfilzomib, Dexamethasone	1
metreleptin	1
Belzutifan, Palbociclib	1
Afimkibart	1
Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 3 microgram dose, Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 6 microgram dose, Bivalent BNT162b2 (original/Omicron BA.4/BA.5) 10 microgram dose, Variant-adapted BNT162b2 (Omicron XBB.1.5) 3 microgram dose	1
Spesolimab	1
Icotrokinra, Active reference comparator	1
BMS-986165	1
LP-184, Olaparib, Nivolumab & Ipilimumab	1
nirmatrelvir, ritonavir	1
TTX-381	1
Adagrasib	1
mRNA-1345	1
INCB177054, Retifanlimab	1
QRX003, 4% Lotion	1
OHB-607	1
ODM-208, Midazolam	1
Pembrolizumab, BCG	1
Artesunate vaginal insert	1
BT5528, Nivolumab	1
IDX-1197+XELOX, IDX-1197+Irinotecan	1
Nusinersen	1
Zanidatamab, Tislelizumab, Trastuzumab, Capecitabine	1
Vevye®, Xiidra®	1
NVG-2089	1
BGM0504, BGM0504, Semaglutide	1
Flu mRNA (Formulation B1), Flu mRNA (Formulation B3), Flu mRNA(Formulation A), Comparator 1	1
BNT162b2 (2025/2026 formulation)	1
BNT162b2 Vaccine	1
Placental Membrane	1
Emavusertib, Ibrutinib	1
Pomalidomide, Dexamethasone, Venetoclax	1
Cenobamate	1
AMXI-5001:Dose Escalation Phase I, AMXI-5001:Dose Expansion Phase II	1
Ranibizumab, ABBV-RGX-314 Dose 1, ABBV-RGX-314 Dose 2, ABBV-RGX-314 Dose 3	1
Zifibancimig, Ranibizumab, Port Delivery Platform	1
Perivascular dexamethasone, Perivascular sham	1
BT7480, Nivolumab	1
AB8939, Venetoclax	1
CFI-402257, Fulvestrant	1
R906289 Monosodium (R289 Na)	1
JAB-2485 (Aurora A inhibitor), JAB-2485 (Aurora A inhibitor)	1
IGC-AD1-Active, IGC-AD1-Placebo	1
Selinexor, Matching Placebo for selinexor	1
mRNA-1647	1
BBT-207	1
Nuwiq	1
KYV-101 anti-CD19 CAR-T cell therapy, Standard lymphodepletion regimen	1
Patidegib Topical Gel, Patidegib Topical Gel with no active patidegib	1
IV Tulisokibart, IV Placebo, SC Tulisokibart, SC Placebo	1
OR502, Cemiplimab	1
Retatrutide, Semaglutide	1
Upadacitinib 15mg Dose, Dupilumab 300mg Dose, Upadacitinib 30mg Dose	1
AOC 1001 (del-desiran)	1
Vosoritide	1
VLS-01-203 BU, VLS-01-BU Placebo	1
VDPHL01	1
CVN424 75 mg, CVN424 150 mg	1
Tarcocimab tedromer, Tabirafusp tedromer, Aflibercept	1
CYB003, Psychological Support	1
JCXH-105, Shingrix	1
PF614 capsule	1
ALTO-100	1
Deucrictibant	1
Domvanalimab, Zimberelimab, Paclitaxel, Carboplatin	1
Azetukalner	1
RDD to Palynziq	1
Mazdutide	1
NE3107	1
iDose TR (travoprost intracameral implant) 75 µg in conjunction with cataract surgery	1
TNP-2092 for injection, Vancomycin Hydrochloride for Injection (IA), Vancomycin Hydrochloride for Injection (IV), Oral antibiotics	1
Erythropoiesis-Stimulating Agent (ESA), Vadadustat	1
Relacorilant 150 mg once daily (QD), Nab-paclitaxel 80 mg/m^2, Bevacizumab 10 mg/kg	1
ATI-045	1
ML-007C-MA BID, ML-007C-MA QD	1
Kedrion IVIG 10%	1
aleniglipron or placebo	1
Stannous fluoride and Potassium nitrate Dentifrice, Stannous fluoride Dentifrice, Potassium nitrate Dentifrice, Vehicle Dentifrice	1
LS301-IT 0.1 mg/kg	1
ABBV-444, REFRESH OPTIVE UD	1
Brelovitug 300 mg, Brelovitug 900 mg, Delayed Treatment with Brelovitug 300mg	1
VYD2311-SD, VYD2311-MD	1
ASC30 tablets	1
aglatimagene besadenovec + valacyclovir, External Beam Radiation Therapy (EBRT)	1
Chloroprocaine Ophthalmic Gel 3% (IHEEZO), Proparacaine Hydrochloride Ophthalmic Solution 0.5%, Lidocaine Hydrochloride Injection 2%	1
ALX006 (bupivacaine extended-release injection), Bupivacaine Hcl 0.25% Inj, Sciatic Nerve Block	1
COVID-19 mRNA vaccine, VYD2311	1
T-DXd	1
JNJ-68284528, Lenalidomide, Daratumumab, Bortezomib	1
Guselkumab	1
BI 1015550, Pirfenidone	1
Amlitelimab, SIGE, Gluten-free product (GFP)	1
Ensifentrine 3 mg, Glycopyrrolate 21.25 mcg, Glycopyrrolate 42.5 mcg	1
Apremilast	1
Efinopegdutide	1
Yellow fever vaccine (live), Yellow fever vaccine (live), Yellow fever vaccine (live), Measles, combinations with mumps and rubella, live attenuated	1
AZD0901, 5-Fluorouracil, Leucovorin, l-leucovorin	1
Autologous genetically modified ADP-A2M4CD8 cells, Autologous genetically modified ADP-A2M4CD8 cells in combination with Nivolumab	1
Petrelintide	1
Nexium 20mg, Nexium 10mg	1
Amnio-Maxx® Dual Layer Amnion Patch	1
rezatapopt, pembrolizumab	1
exidavnemab	1
Raludotatug Deruxtecan (R-DXd)	1
REGN7075, Cemiplimab, Platinum-based doublet chemotherapy, Bevacizumab	1
pembrolizumab/vibostolimab, durvalumab, cisplatin, pemetrexed	1
CAB LA + RPV LA, Oral ART	1
NDV-HXP-S-KP.2, COVID-19 mRNA Vaccine	1
RINVOQ LQ	1
Vicadrostat, Empagliflozin	1
Avelumab	1
CagriSema (Cagrilintide B and Semaglutide I)	1
NT-0796	1
PF-07220060 + PF-07104091 combination dose escalation, PF-07220060 + PF-07104091 combination dose escalation, PF-07220060 + PF-07104091 combination dose escalation, PF-07220060 + PF-07104091 combination dose escalation	1
Brivaracetam	1
AZD9833, Anastrozole, Anastrozole placebo, AZD9833 placebo	1
Danicopan	1
RO7204239, RO7204239 Matching Placebo, Tirzepatide	1
BPM31510, Vitamin K1, Temozolomide (TMZ), Radiation	1
JDQ443, docetaxel	1
Rilzabrutinib dose 1, Rilzabrutinib dose 2	1
Satralizumab	1
Lutetium (177Lu) rhPSMA-10.1 Injection, 18F-rhPSMA-7.3 injection (in phase 1 only)	1
teplizumab	1
AZD2936	1
Giredestrant	1
Alectinib, Cisplatin, Carboplatin, Pemetrexed	1
SBP-101, Nab-paclitaxel, Gemcitabine	1
PTX-9908 Injection	1
ONC-392, Pembrolizumab	1
Elranatamab, Elotuzumab, Pomalidomide, Dexamethasone	1
RCT2100, RCT2100, RCT2100, Ivacaftor	1
NPT 2042	1
zolbetuximab, nab-paclitaxel, gemcitabine	1
Trastuzumab deruxtecan, Ramucirumab, Paclitaxel	1
rAAV-Olig001-ASPA, Levetiracetam, Prednisone	1
avutometinib (VS-6766) and defactinib in combination with gemcitabine and nab-paclitaxel	1
Abelacimab	1
Sefaxersen (RO7434656)	1
Cilta-cel, Talquetamab	1
NBQ72S	1
HS-20093, Gemcitabine combined with docetaxel	1
RSVpreF	1
Filgotinib	1
TAF	1
AMDC-USR (iltamiocel)	1
Baricitinib, Tocilizumab	1
PMD-026, fulvestrant	1
Selinexor, Physician's Choice Treatment	1
Qudexy XR	1
Tafasitamab, Lenalidomide, Rituximab, Cyclophosphamide	1
64Cu-SAR-bisPSMA, 67Cu-SAR-bisPSMA	1
Sacituzumab Govitecan-hziy (SG), Pembrolizumab, Carboplatin, Cisplatin	1
Sevasemten 10 mg, Sevasemten 5 mg, Sevasemten 12.5 mg	1
OLZ/SAM, Olanzapine	1
ORIC-114, Chemotherapy drug	1
SLN124	1
ARV-471, Abemaciclib	1
Tenapanor 50 MG, Tenapanor 25 mg bid	1
Drug: Normal Saline, Sovateltide	1
RiMO-301	1
AGMB-129	1
Lumateperone	1
DPI-386 Nasal Gel, Other (e.g., promethazine, meclizine)	1
GIM122	1
64Cu-SAR-bisPSMA	1
Dostarlimab, Belrestotug, Nelistotug, Remzistotug	1
AC-203, Vehicle	1
Piflufolastat F 18 Intravenous Solution [PYLARIFY]	1
TOUR006 - 20 MG, TOUR006 - 50 MG	1
Adalimumab, Risankizumab	1
Miricorilant (Cohort A), Miricorilant (Cohort B)	1
fenfluramine	1
Axatilimab	1
Copper Cu 64 PSMA I&T	1
Cadisegliatin 800 mg QD, Cadisegliatin 800 mg BID	1
LY3650150, Standard therapy for INCS	1
WVE-006	1
AMDX-2011P	1
AMOR-1, Crystalline Calcium Carbonate	1
PCS6422 and capecitabine, Capecitabine	1
Ranibizumab, EYE103	1
NNC0519-0130, Semaglutide	1
Empasiprubart, IVIG (Intravenous Immunoglobulin), Empasiprubart-placebo, IVIg-placebo	1
CK-4021586 (150 mg, 300 mg, 450 mg, and 600 mg)	1
MZE829	1
AR882 50 mg, AR882 75 mg	1
Bemnifosbuvir-Ruzasvir (BEM/RZR), Sofosbuvir-Velpatasvir (SOF/VEL)	1
DISC-1459	1
human retinal progenitor cells, Mock injection	1
Obicetrapib 10mg	1
Atacicept	1
DT-168	1
Neflamapimod	1
RAP-219	1
Trichostatin A	1
VSJ-110	1
Nenocorilant 200 mg, Nenocorilant 300 mg, Nenocorilant 400 mg, Nivolumab	1
Taldefgrobep Alfa, Taldefgrobep Alfa	1
Aleniglipron	1
GLK-321 low dose BID, GLK-321 mid dose BID, GLK-321 high dose BID, GLK-321 high dose QD	1
PF-07868489	1
zongertinib, pembrolizumab, cisplatin, carboplatin	1
Methamphetamine, Sterile Saline, CS-1103	1
Eptinezumab	1
BMS-986490, Bevacizumab	1
Tulisokibart, Methotrexate	1
CAB LA, New formulation of CAB LA	1
Candidate varicella vaccine, Marketed varicella vaccine, MMR vaccine, Hepatitis A vaccine	1
NS-089/NCNP-02	1
Brepocitinib PO QD	1
BAY2599023 (DTX201)	1
Pembrolizumab, Carboplatin, Paclitaxel, Docetaxel	1
TEV-53408	1
MET233 and MET097, MET097	1
Biological/Vaccine	1
Topotecan - usual, Topotecan - study	1
Fp/ABS, FP, ABS	1
VHB937	1
CardiolRx	1
T3011, T3011 + pembrolizumab	1
mRNA-1403, mRNA-1405	1
PF-07220060, Letrozole, Fulvestrant, Midazolam	1
YTB323	1
AT02	1
OCU410ST	1
Sonelokimab	1
Depemokimab, Mepolizumab	1
NaBen®	1
BI-1206, Rituximab, Acalabrutinib	1
Oral repotrectinib (TPX-0005)	1
Linerixibat	1
BCV	1
Glofitamab, Tocilizumab, Doxorubicin, Vincristine	1
Durvalumab, Oleclumab, Monalizumab	1
JDQ443, trametinib, Ribociclib, cetuximab	1
JIN-A02	1
OM-85	1